P. Geppetti (Florence, Italy), D. Cataldo (Liege, Belgium)
Pro-inflammatory role of the nuclear kinase MSK1 in asthma
L. Reber, F. Daubeuf, N. Frossard (Illkirch, France)
|   |
Anti-CD25 antibody daclizumab reduces airway eosinophilia induced by ascaris suum challenge in atopic monkeys
V. Vexler, J. Sheridan, L. Efros, D. Chao, A. Albano, E. Martin, R. Murray (Redwood City, CA, Worcester, MA, United States Of America)
| |
Toxicity and pharmacodynamics of Cy317HuXCy, a surrogate for AMG 317, in cynomolgus monkeys
M. Horner, L. Carlock, B. Boren, A. Mould, R. Armitage, T. Kakkar, J. Bussiere (Thousand Oaks, CA, Seattle, WA, Madison, WI, United States Of America)
| |
Anti-inflammatory effects of sevoflurane anesthesia in an experimental model of chronic allergic asthma
D. Ornellas, S. Burburan, D. Xisto, M. Morales, P. Rocco (Rio de Janeiro, Brazil)
| |
Tissue accumulation kinetics of ciclesonide-active metabolite and budesonide in mice
U. Mårs, R. DÁrgy, E. Evetovics, P. Sjölin, A. Miller-Larsson, S. Edsbäcker (Södertälje, Lund, Sweden)
| |
Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in the airway remodeling induced by chronic airway inflammation in guinea pigs
E. Leick-Maldonado, C. Prado, M. Martins, I. Tibério (São Paulo, Brazil)
| |
Budesonide and formoterol rapidly and effectively inhibit ERK1/2 phosphorylation in bradykinin-stimulated human lung fibroblasts
F. Sabatini, L. Petecchia, S. Boero, M. Silvestri, G. A. Rossi, F. L. M. Ricciardolo (Genoa, Turin, Italy)
| |
Pharmacokinetics and safety of aclidinium bromide, a novel long-acting, inhaled anticholinergic, in healthy subjects
E. Garcia Gil, P. Ferrer, J. Jansat (Barcelona, Spain; Papeete, French Polynesia)
| |
Bronchodilator therapies reduce oxidant stress and LTB4 activation in chronic obstructive pulmonary disease subjects
P. Santus, C. Buccellati, S. Centanni, F. Fumagalli, F. Di Marco, P. Busatto, A. Sala (Italia, Italy)
| |
Correction of daily blood pressure changes in COPD patients by using AT1-receptors inhibitors
L. Anton, R. Viktoria, V. Elena (Dnepropetrovsk, Ukraine)
| |
Monitoring of inflammatory changes in patients with bronchial asthma before and after oral corticosteroid treatment
M. Ivana, T. Milan, R. Olga, F. Zuzana, P. Petr (Plzen, Czech Republic)
| |
Antiinflammatory effects of formoterol in macrophages as a model for alveolar macrophages in COPD
B. Burian, B. Marzluf, A. Storka, V. Petkov (Vienna, Austria)
| |
Antioxidant activity of anticholinergic bronchodilatators
U. Farkhutdinov, S. Farkhutdinov, L. Oleinik (Ufa, Russian Federation)
| |
Improvement of control and quality of life in severe allergic asthmatics patients treated with omalizumab
A. Pacheco, M. Hinojosa, J. Gonzalez, B. Huertas, D. Antolin, C. Vidal (Madrid, Spain)
| |
Safety and tolerability of aerosolized human alpha-1 antitrypsin (AAT): a phase Ia/Ib clinical study
M. R. Kramer, D. Shitrit, N. Tov, P. Strauss, L. Yehoshua, S. Bauer (Petach Tikva, Science Park, Ness Ziona, Israel)
| |
Aclidinium bromide, a novel long-acting anticholinergic, does not affect QT interval in healthy subjects
E. Garcia Gil, J. Aubets, K. Lasseter (Barcelona, Miami, Spain; Miami, United States Of America)
| |
Stimulation of CFTR-dependent chloride secretion by roflumilast
N. Pedemonte, L. Galietta (Genova, Italy)
| |
Development of diabetes mellitus in patients with bronchial asthma
G. Moskovljevic, J. Moskovljevic (Varvarin, Nis, Serbia And Montenegro)
| |